Alphabetical search
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z
Search by Name or Code Test
(Para exportar a PDF debe añadir la ténica a Mi Lista y lickar en Ver Mi lista, selección máxima 25 técnicas)
4
LEUKOCYTE DIFFERENTIAL, BLOOD
Method:
Cytometry/Cytochemical.
Mounting:
Delivery period:1
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Eosinófilos:
1.00 - 6.00 %
Linfocitos:
1300.00 - 4000.00 cel/mm³
Neutrófilos Cayados:
0.20 - 4.00 %
< 500.00 cel/mm³
Neutrófilos Segmentados:
55.00 - 70.00 %
Basófilos:
0.20 - 1.20 %
10.00 - 150.00 cel/mm³
Eosinófilos:
50.00 - 500.00 cel/mm³
Monocitos:
2.00 - 8.00 %
150.00 - 900.00 cel/mm³
Linfocitos:
17.00 - 45.00 %
Neutrófilos Segmentados:
2500.00 - 7500.00 cel/mm³
Review:
01/06/2005
417
LACTIC ACID (LACTATE), PLASMA
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:
0.50 - 2.20 mmol/L * 9.00901 = mg/dL
Review:
09/04/2013
508
LDH (LACTATE DEHYDROGENASE), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
2.08 - 4.05 uKat/L * 59.988 = U/L
Review:
09/04/2013
509
LDH ISOENZYMES, SERUM
Method:
Agarose gel electrophoresis.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
LDH 1:
20.60 - 32.00 %
LDH 2:
31.10 - 35.90 %
LDH 3:
19.80 - 25.70 %
LDH 4:
7.00 - 10.40 %
LDH 5:
6.50 - 14.00 %
Review:
09/07/2013
524
LIPASE (TRIACYLGLYCEROL LIPASE), SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Reference V.:
0.13 - 1.30 uKat/L * 59.988 = U/L
Review:
09/04/2013
526
LEUCINE AMINOPEPTIDASE, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
0.33 - 0.92 uKat/L * 60.0 = U/L
555
LIPIDS, SERUM
Method:
Turbidimetry.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
4.50 - 8.00 g/L
Review:
22/06/2013
569
LIPID PANEL, SERUM
Method:
Agarose gel electrophoresis.
Mounting:
Delivery period:4
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
1.10 - 3.10
2.20 - 6.20
Alfa lipoproteína:
10.00 - 47.00 %
Pre beta lipoproteína:
5.00 - 25.00 %
Quilomicrones:
< 2.00 %
Beta lipoproteína:
37.00 - 67.00 %
Review:
09/07/2013
574
LDL CHOLESTEROL, SERUM
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)
Interpretation:
NCEP Panel III High:
4.13 - 4.89 mmol/L * 38.6 = mg/dL
Almost optimal:
2.58 - 3.34 mmol/L * 38.6 = mg/dL
Near High:
3.35 - 4.12 mmol/L * 38.6 = mg/dL
Very high:
> 4.89 mmol/L * 38.6 = mg/dL
Optimal:
< 2.58 mmol/L * 38.6 = mg/dL
Reference V.:
< 2.58 mmol/L * 38.6 = mg/dL
Review:
09/04/2013
582
LIPOPROTEIN (a), SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Reference V.:
< 300.00 mg/L * 0.1 = mg/dL
Review:
18/08/2009
761
LYSOZYME (MURAMIDASE), SERUM
Method:
Immunoturbidimetry.
Mounting:
Delivery period:5
Sample:
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
2.50 - 8.00 mg/L * 0.1 = mg/dL
Review:
16/05/2013
907
LEPTIN, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:22
Sample:
1 mL Serum (-8 ºC - Freeze)
Request form:
Age is required.
Weight is required.
Height is required.
Gender is required.
Interpretation:

BMI (18 - 25) Females 3.00 - 12.00 ng/mL
Males 2.00 - 6.00 ng/mL
R.Values:
BMI is calculated by dividing weight by the square of the height.
1065
LH (LUTROPIN), SERUM
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:

Luteal phase Females 0.90 - 9.33 UI/L
Menopause Females 10.39 - 64.57 UI/L
Males 1.14 - 8.75 UI/L
Ovulatory peak Females 9.06 - 74.24 UI/L
Folicular phase Females 2.39 - 6.60 UI/L
Review:
09/04/2013
1234
LITHIUM ION, SERUM
1278
LEAD, BLOOD
Method:
Atomic absorption Spectrometry (Graphite furnace).
Mounting:
Delivery period:2
Sample:
1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Sample extraction:
Metal-free tubes (special for the determination of oligoelements) must be used.
BLV:

Exposed personnel (Lead and ionic lead products) < 3380.00 nmol/L * 0.020704 = ug/dL
Reference V.:

Unexposed personnel < 1207.00 nmol/L * 0.020704 = ug/dL
Review:
10/02/2014
1290
LEVOMEPROMAZINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
10.00 - 140.00 ug/L
Toxic C.:
> 500.00 ug/L
Review:
05/03/2004
1323
LIDOCAINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:12
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Therapeutic R.:
1.50 - 6.00 ug/mL
Toxic C.:
> 6.00 ug/mL
Review:
05/03/2004
1402
LUPUS ANTICOAGULANT, PLASMA
Method:
Coagulometry.
Mounting:
Delivery period:5
Sample:
1 mL Plasma Sodium Citrate (-8 ºC - Freeze)
Sample extraction:
Add 1 volume of sodium citrate 3.80% for every 9 volumes of blood.
Centrifuge.
Separate plasma.
Freeze specimen immediately.
Interpretation:
Weak positive: 1.20 - 1.50
Moderate positive:
1.51 - 2.00
High positive:
> 2.00
Negative:
< 1.20
1487
LKM-1 (LIVER KIDNEY MICROSOME) ANTIBODIES, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/40 Titulo
Negative:
< 1/40 Titulo
Review:
21/06/2013
1491
LEGIONELLA PNEUMOPHILA ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/24 Titulo
Negative:
< 1/24 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
06/03/2009
1492
LEGIONELLA PNEUMOPHILA ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Please mark specimens clearly as "acute" or "convalescent."
Interpretation:
Negative: < 1/128 Titulo
Positive:
>= to 1/128 Titulo
R.Values:
The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.
Review:
28/04/2009
1493
LEISHMANIA spp. ANTIBODIES, IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/80 Titulo
Positive:
>= to 1/80 Titulo
Review:
28/04/2009
1494
LEPTOSPIRA INTERROGANS ANTIBODIES, SERUM
Method:
Agglutination.
Mounting:
Delivery period:1
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
1495
LISTERIA MONOCYTOGENES ANTIBODIES, SERUM
Method:
Complement fixation.
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/32 Titulo
Negative:
< 1/32 Titulo
Review:
22/05/2013
1496
LEGIONELLA PNEUMOPHILA DNA, RESPIRATORY SPECIMEN
Method:
Polymerase chain reaction.
Mounting:
Delivery period:13
Sample:
Alt. 1 mL BAL (-8 ºC - Freeze)
Alt. 1 mL BAS (-8 ºC - Freeze)
1 mL Sputum/phlegm (-8 ºC - Freeze)
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Freeze specimen immediately.
Reference V.:
Negative
1497
LC-1 (LIVER CYTOSOL ANTIGEN) ANTIBODIES, SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
1499
LEISHMANIA spp. ANTIBODIES, IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1/24 Titulo
Negative:
< 1/24 Titulo
Review:
28/04/2009
1743
LIPASES ACIDES, LYMPHOCYTES
Method:
Fluorimetry
Mounting:
Delivery period:32
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..
Reference V.:
1266.00 - 1852.00 nmol/hxmg Prt
557.00 - 1010.00 nmol/hxmg Prt
1855
LYSOZYME (MURAMIDASE), URINE
Method:
Immunoturbidimetry.
Mounting:
Delivery period:5
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
< 2.00 mg/L * 0.1 = mg/dL
Review:
10/07/2013
1860
LEUCINE AMINOPEPTIDASE, URINE
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
25.00 - 183.00 nKat/L / 16.6 = U/L
1975
LSD (LYSERGIC DIETHYLAMIDE ACID) SCREENING, URINE
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:11
Sample:
1 mL Urine (-8 ºC - Freeze)
Discriminant V.:
0.50 ug/L
Reference V.:
Negative
2012
LH (LUTROPIN), URINE
Method:
Immunochemiluminiscence.
Mounting:
Delivery period:1
Sample:
1 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)
Request form:
Diuresis required
Reference V.:
Males 9.00 - 23.00 UI/24h
Females 4.00 - 30.00 UI/24h
Review:
09/04/2013
2049
LSD (LYSERGIC DIETHYLAMIDE ACID) CONFIRMATORY, URINE
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:15
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
Negative
2113
LEBER HEREDITARY OPTICNEUROPATHY (LHON), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
29/04/2004
2115
LACTIC ACID (LACTATE), CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Both > 14 Years 1.10 - 2.40 mmol/L
Both 0 10 Days 1.10 - 6.70 mmol/L
Both 1 14 Years 1.10 - 2.80 mmol/L
Both 11 365 Days 1.10 - 2.80 mmol/L
2139
LDH (LACTATE DEHYDROGENASE), PLEURAL FLUID
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Interpretation:
Exudates: > 60% of serum concentration.
Transudates:
< 60% of serum concentration.
2140
LYSOZYME (MURAMIDASE), PLEURAL FLUID
Method:
Immunoturbidimetry.
Mounting:
Delivery period:5
Sample:
1 mL Biologic fluid (2-8 ºC - Refrigerate)
Reference V.:
< 12.00 mg/L
Review:
10/07/2013
2160
LEVETIRACETAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:5
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Therapeutic R.:
10.00 - 37.00 mg/L * 5.875 = µmol/L
Toxic C.:
> 400.00 mg/L * 5.875 = µmol/L
Review:
28/01/2008
2201
LEVODOPA, SERUM
Method:
High efficiency liquid chromatography.
Mounting:
Delivery period:8
Sample:
2 mL Serum (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Therapeutic R.:
0.20 - 2.50 mg/L
Review:
23/11/2011
2388
LEAD, URINE
Method:
Atomic absorption Spectrometry (Graphite furnace).
Mounting:
Delivery period:2
Sample:
10 mL Urine Nitric Acid (2-8 ºC - Refrigerate) pH=2
BEI:

Exposed personnel (Lead and ionic lead products) <= to 720.00 nmol/g creat. * 0.207 = ug/g creat.
Reference V.:

Unexposed personnel < 240.00 nmol/g creat. * 0.207 = ug/g creat.
Review:
23/11/2010
2521
LH (LUTROPIN), SERUM 15 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 15 m. (2-8 ºC - Refrigerate)
Reference V.:
Not available
2522
LH (LUTROPIN), SERUM 30 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 30m (2-8 ºC - Refrigerate)
Reference V.:
Not available
2523
LH (LUTROPIN), SERUM 45 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 45 m. (2-8 ºC - Refrigerate)
Reference V.:
Not available
2524
LH (LUTROPIN), SERUM 60 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 60m (2-8 ºC - Refrigerate)
Reference V.:
Not available
2525
LH (LUTROPIN), SERUM 90 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 90m (2-8 ºC - Refrigerate)
Reference V.:
Not available
2526
LH (LUTROPIN), SERUM 120 m
Method:
Chemicalimmuno luminiscense.
Mounting:
Delivery period:1
Sample:
1 mL Serum 120m (2-8 ºC - Refrigerate)
Reference V.:
Not available
5286
LUNG CANCER (EGFR GENE: EXONS 18 - 21), BIOPSY
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
1 Sample/s Parafined tissue (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Reported for each case
Review:
24/03/2011
6207
LEAD, DIALYSATE
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)
UNE 111-301-90:
< 0.005 mg/L
6224
LEAD, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
RD 140/2003:
< 25.00 ug/L
6225
LITHIUM, WATER
Method:
Atomic emission Spectrometry.
Mounting:
Delivery period:1
Sample:
100 mL Water (Recipient, plastic)
Parametric V.:
Not established.
Review:
07/08/2009
6308
LIME, DRINKING WATER
Method:
Calculation
Mounting:
Delivery period:10
Sample:
150 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Dureza Total:
Soft water: 0.00 - 75.00 mg CaCO3/L / 10.0 = ºF
Hard water:
150.01 - 300.00 mg CaCO3/L / 10.0 = ºF
Slightly hard water:
75.01 - 150.00 mg CaCO3/L / 10.0 = ºF
Very hard water:
> 300.00 mg CaCO3/L / 10.0 = ºF
Cal:
Not established.
6542
LEGIONELLA IDENTIFICATION, WATER
Method:
ISO 11731: 1998 (Detection and enumeration of Legionella)
Mounting:
Delivery period:16
Sample:
1000 mL Water (2-8 ºC - Refrigerate)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Reference V.:
Identif. L.pneumophila serogroup 1:
Parametric V.:
Legionella Identification:
Negative
6662
LEAD, WASTE WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
DC 130/2003:
< 1.00 mg/L
RD 849/1986:
Type I spill.: 0.21 - 0.50 mg/L
Type III spill.:
<= to 0.20 mg/L
6663
LEAD, WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6755
LEAD, DRINKING WATER
Method:
Inductively coupled plasma mass spectrometry
Mounting:
Delivery period:5
Sample:
50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)
Parametric V.:
Not established.
6830
LEGIONELLA PNEUMOFILA ADN, WATER
Method:
Real Time PCR.
Mounting:
Delivery period:5
Sample:
1000 mL Water (Recipient, sterile)
Sample extraction:
Specimens of chlorinated water and brominated water must be collected in a recipient containing thiosulfate.
Add 0.10 mL of a 10% (m/m) solution of sodium thiosulfate per 125 mL of specimen.
Parametric V.:
Is not detected
7036
LEGIONELLA ANTIGEN, URINE
Method:
EIA Chromatography.
Mounting:
Delivery period:2
Sample:
10 mL Urine (2-8 ºC - Refrigerate)
Sample extraction:
See general instructions.
Reference V.:
Negative
8030
LEIGH SYNDROME (T8993C/T8993G MUTATIONS: MT-ATP6 GENE) , BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
11/02/2005
8075
LEISHMANIA spp. ANTIBODIES, IgA, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:3
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/80 Titulo
Positive:
>= to 1/80 Titulo
Review:
28/04/2009
8118
LACTOFERRIN, FECAL
Method:
Qualitative Immunochromatographie.
Mounting:
Delivery period:15
Sample:
1 g Faeces (-8 ºC - Freeze)
Sample extraction:
Freeze specimen immediately.
Reference V.:
Negative
8279
LIMB-GIRDLE MUSCULAR DYSTROPHY 2A (LGMD2A) (CAPN3 GENE: SEQ), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
07/03/2013
8448
LYMPHOPROLIFERATIVE DISORDERS IMMUNOPHENOTYPE, BONY MARROW
Method:
Flux cytometry.
Mounting:
Delivery period:6
Sample:
1 mL Bone marrow (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
The type of specimen sent is required.
Sample extraction:
Specimens must be delivered to the laboratory from Monday to Thursday.
R.Values:
Reported for each case.
8477
LEFLUNOMIDE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:11
Sample:
1 mL Serum (-8 ºC - Freeze)
Therapeutic R.:

25 mg dose 27.00 - 99.00 mg/L
10 mg dose 8.40 - 27.60 mg/L
5 mg dose 5.90 - 11.70 mg/L
8560
LACTOSE TOLERANCE TEST, EXPIRED AIR
Method:
Mass Spectrometry.
Mounting:
Delivery period:10
Sample:
1 Sample/s Post-baseline expired air 90 m (12-20 ºC - Ambient Temp.)
1 Sample/s Post-baseline expired air 180 m (12-20 ºC - Ambient Temp.)
1 Sample/s Post-baseline expired air 30 m (12-20 ºC - Ambient Temp.)
1 Sample/s Post-baseline expired air 60 m (12-20 ºC - Ambient Temp.)
1 Sample/s Baseline expired air (12-20 ºC - Ambient Temp.)
1 Sample/s Post-baseline expired air 120 m (12-20 ºC - Ambient Temp.)
1 Sample/s Post-baseline expired air 150 m (12-20 ºC - Ambient Temp.)
Reference V.:
Negative
8755
LYMPHOPROLIFERATIVE DISORDERS IMMUNOPHENOTYPE, BLOOD
Method:
Flow cytometry.
Mounting:
Delivery period:6
Sample:
10 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Alt. 1 mL Bone marrow (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
The type of specimen sent is required.
Sample extraction:
Specimens must be delivered to the laboratory from Monday to Thursday.
Reference V.:
Antígeno CD19:
Reported for each case
COMENTARIO:
Reported for each case
R.Values:
Reported for each case.
Review:
24/09/2009
8951
LEPTOSPIRA ANTIBODIES IgG, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:7
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/256 Título
Reference V.:
Positive: >= to 1/256 Título
Review:
04/06/2012
8952
LEPTOSPIRA ANTIBODIES IgM, SERUM
Method:
Indirect Immunofluorescense.
Mounting:
Delivery period:7
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Negative: < 1/40 Título
Reference V.:
Positive: >= to 1/40 Título
Review:
06/04/2012
10020
LYNCH SYNDROME (HNPCC) (MLH1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
19/07/2010
10021
LYNCH SYNDROME (HNPCC) (MSH2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
19/07/2010
10022
LYNCH SYNDROME (CCHNP) (MSH6 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:45
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
19/07/2010
10047
LEUKOCYTE CYSTINE, BLOOD
Method:
Gas Chromatography - Mass spectrometry.
Mounting:
Delivery period:30
Sample:
10 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)
Sample extraction:
Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.
Reference V.:
< 0.50 nmol/mg.prot
10131
LACTOSE INTOLERANCE (LCT GENE), BLOOD
Mounting:
Delivery period:10
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not use heparin as an anticoagulant.
Reference V.:
Reported for each case
Review:
08/07/2014
10195
LEISHMANIA DONOVANI COMPLEX DNA, BIOLOGICAL FLUID
Method:
PCR-Real Time-Sequencing.
Mounting:
Delivery period:21
Sample:

1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 piece/s Biopsy (-8 ºC - Freeze)
Reference V.:
Negative
Review:
10/06/2011
10235
LAMBDA FREE LIGHT CHAIN, URINE
Method:
Immunonephelometry.
Mounting:
Delivery period:7
Sample:
2 mL Urine (2-8 ºC - Refrigerate)
Reference V.:
0.24 - 6.66 mg/L
10243
LACTOFERRIN ANTIBODIES, SERUM
Method:
Enzyme-Linked Immunoassay.
Mounting:
Delivery period:25
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.01 Indice
Negative:
< 1.01 Indice
10701
LIMB-GIRDLE MUESCULAR DYSTROPHY 2A (CAPN3 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10702
LIMB-GIRDLE MUSCULAR DSTROPHY 2A (LGMD2A) (CAPN3 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10716
LATERAL AMYOTROPHIC SCGLEROSIS (SOD1 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10788
LEOPARD SYNDROME (PTPN11 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10789
LEOPARD SYNDROME (PTPN11 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10790
LIPODYSTROPHY CONG BERARDINELLI-SEIP 2 (GEN BSCL2: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10791
LIPODYSTROPHY CONGENITAL BERARDINELLI-SEIP TYPE 2 (BSCL2 GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10793
LOEYS-DIETZ SYNDROME TYPE 2 (TGFBR2 GENE: SEQUENCING), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10939
LYNCH SYNDROME (CCHNP) (GEN MLH1: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10940
LYNCH SyNDROME (CCHNP) (MLH1 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10943
LYNCH SYNDROME (CCHNP) (MSH2 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10944
LYNCH SYNDROME (CCHNP) (MSH2 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
10955
LYNCH SYNDROME (CCHNP) (PMS2 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11006
LIPODYSTROPHY CONGENITAL BERARDINELLI-SEIP 2 (BSCL2 GENE), C. VILLI
Method:
PCR-Sequencing.
Mounting:
Delivery period:30
Sample:
0.01 g Corial villus (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
11025
LYNCH SYNDROME (CCHNP) (MSH6 GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11026
LYNCH SYNDROME (CCHNP) (MSH6 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11117
LARON SYNDROME (GHR GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11195
LIMB GIRDLE MUSCULAR DYSTROPHY 1C (LGMD1C) (CAV3 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
03/09/2012
11233
LGI1 NEURONAL ANTIBODIES, SERUM
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
11571
LIMPHOHISTIOCYTOSIS HEMOPHAGOCYTIC FAMILIAL 2 (GEN PRF1: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
02/01/2014
11572
LIMPHOHISTIOCYTOSIS HEMOPHAGOCYTIC FAMILIAL 2 (PRF1 GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11605
LISTERIA MONOCYTOGENES DNA, BIOLOGICAL FLUID
11828
LKM-1 (LIVER KIDNEY MICROSOME) ANTIBODIES (IMMUNOBLOT), SERUM
Method:
Immunoblot.
Mounting:
Delivery period:10
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
11852
LIMB-GIRDLE MUSCULAR DISTROPHY 1E (DNAJB6 GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:75
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11853
LIMB-GIRDLE MUSCULAR DISTROPHY 1B (LGMD1B) (LMNA GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
11854
LIMB-GIRDLE MUSCULAR DISTROPHY 1A (LGMD1A) (MYOT GENE: SEQ.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
Review:
25/11/2013
11994
LEISHMANIA spp DNA, BLOOD
Method:
Real Time PCR.
Mounting:
Delivery period:12
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
05/05/2014
14236
LEPTOSPIRA INTERROGANS TOTAL ANTIBODIES (TAM), SERUM
Method:
Microscopic agglutination test (MAT).
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
09/09/2014
14344
LEISHMANIA spp DNA, BONE MARROW
Method:
Real Time PCR.
Mounting:
Delivery period:12
Sample:
2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)
Reference V.:
Negative
Review:
05/01/2015
14614
Lymphocytes Th17 (CD4+CCR4+CCR6+CCR7-) %
Method:
Flow cytometry.
Mounting:
Delivery period:12
Sample:
5 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
2.10 - 11.50 %
14629
LISSENCEPHALY TIPE 1 X LINKED (DCX GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14630
LISSENCEPHALY TYPE 1 X LINKED (DCX GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14631
LISSENCEPHALY TYPE 1 X LINKED (DCX GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14645
LGI1 NEURONAL ANTIBODIES, CSF
Method:
Imunocitochemistry (Cell Based Assay) .
Mounting:
Delivery period:21
Sample:
0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
Negative
14702
LEUCOCYTES, FECES
Method:
Microscopic observation.
Mounting:
Delivery period:3
Sample:
20 g Diarrhea stool (2-8 ºC - Refrigerate)
Reference V.:
Negative
14791
LOEYS-DIETZ SYNDROME TYPE 1 (TGFBR1 GENE: NGS), BLOOD
Method:
Next Generation Sequencing (NGS)
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14845
LACTOGEN PLACENTARY, SERUM
Method:
Inmunodifusion.
Mounting:
Delivery period:7
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Reference V.:

Gestation Females 28 Weeks 2.10 - 5.80 ug/mL
Females 12 Weeks 0.10 - 0.60 ug/mL
Females 40 Weeks 3.10 - 9.00 ug/mL
Females 20 Weeks 0.90 - 2.50 ug/mL
14852
LIDDLE SYNDROME (SCNN1B GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14853
LIDDLE SYNDROME (SCNN1G GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14858
LDH (LACTATE DEHYDROGENASE), CSF
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
Reference V.:
< 0.41 uKat/L * 59.988 = U/L
Review:
03/09/2015
14935
LECITHIN CHOLESTEROL ACYLTRANSFERASE DEFICIENCY (LCAT GENE), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14956
LIPOPROTEIN LIPASE DEFICIENCY (LPL GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
14957
LIPOPROTEIN LIPASE DEFICIENCY (LPL GENE: KNOWN M.), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15009
LYNCH SYNDROME (CCHNP) (EPCAM GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15012
LYNCH SYNDROME (CCHNP) (PMS2 GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification).
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15013
LYNCH SYNDROME (CCHNP) (EPCAM GENE: MLPA), BLOOD
Method:
MLPA (Multiplex Ligation-dependent Probe Amplification)
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15016
LACTIC ACID (LACTATE), PLASMA Basal
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Baseline plasma Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:
0.50 - 2.20 mmol/L * 9.00901 = mg/dL
15017
LACTIC ACID (LACTATE), PLASMA 1 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 1 m. Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:

15018
LACTIC ACID (LACTATE), PLASMA 3 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 3 m. Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:

15019
LACTIC ACID (LACTATE), PLASMA 6 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 6 m. Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:

15020
LACTIC ACID (LACTATE), PLASMA 10 m
Method:
Molecular absorption Spectrometry.
Mounting:
Delivery period:1
Sample:
1 mL Plasma 10 m. Sodium fluoride (2-8 ºC - Refrigerate)
Reference V.:

15065
LIPODYSTROPHY PARCIAL TYPE II (LMNA GENE: SEQUENCING), AMNIOTIC FLUID
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Sample extraction:
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.
Reference V.:
Reported for each case
15082
LEISHMANIA spp DNA, BIOPSY
Method:
Real Time PCR.
Mounting:
Delivery period:12
Sample:
1 piece/s Biopsy (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Negative
15113
LARSEN SYNDROME (FLNB GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15318
LRP4 ANTIBODIES, SERUM
Method:
Immunocytochemistry
Mounting:
Delivery period:15
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Reference V.:
Negative
15378
LEISHMANIA DONOVANI COMPLEX DNA, BIOPSY
Method:
PCR-Sequencing.
Mounting:
Delivery period:21
Sample:
1 piece/s Biopsy Physiological serum (12-20 ºC - Ambient Temp.)
Request form:
Clinical information required.
Reference V.:
Negative
15412
LOEYS-DIETZ SYNDROME TYPE 1 (TGFBR1 GENE: SEQUENCING), BLOOD
15582
LYNCH SYNDROME (CCHNP) (PMS2 GENE: KNOWN MUTATION), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15631
LHCGR GENE (Asn312Ser POLYMORPHISM), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:35
Sample:
3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15664
La (SS-B) ANTIBODIES, SERUM
Method:
Multiplex Fluorometric ImmunoAssay
Mounting:
Delivery period:2
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Interpretation:
Positive: >= to 1.00 IA
Negative:
< 1.00 IA
15702
LARSEN SYNDROME (FLNB GENE: SECUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case
15723
LACOSAMIDE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
1.00 - 10.00 mg/L * 3.995 = µmol/L
15724
LAMOTRIGINE, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:6
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
3.00 - 14.00 mg/L * 3.905 = µmol/L
15755
LORMETAZEPAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
5.00 - 25.00 µg/L * 0.002983 = µmol/L
15756
LORAZEPAM, SERUM
Method:
High efficiency liquid chromatography - Mass spectrometry.
Mounting:
Delivery period:8
Sample:
1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Therapeutic R.:
20.00 - 250.00 µg/L * 0.003114 = µmol/L
15771
LONG QT 3 SYNDROME (SCN5A GENE: SEQUENCING), BLOOD
Method:
PCR-Sequencing.
Mounting:
Delivery period:65
Sample:
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Request form:
Clinical information required.
Sample extraction:
Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Reference V.:
Reported for each case